GlassScriptPhysician profile
Robin Y Lee
NPI 1801098405
$4,968.23
in general payments reported to CMS, 2019-2025
47 companies · $1,369 in 2025
The $1,369 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $865 · 2020: $267 · 2021: $71.30 · 2022: $597 · 2023: $804 · 2024: $995 · 2025: $1,369.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,169.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,168.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $526.65 | 2019-2025 | Erleada |
| C. R. Bard, INC. & Subsidiaries | $271.62 | 2019-2025 | Bard Urinary Drainage Bag |
| Astellas Pharma US INC | $269.87 | 2019-2023 | Myrbetriq |
| Edap Technomed INC | $204.02 | 2023 | |
| Myriad Genetic Laboratories, INC. | $196.22 | 2020-2024 | Prolaris, Precisetumor |
| Boston Scientific Corporation | $178.63 | 2019-2025 | Lithovue, Rezum Generator |
| Teleflex LLC | $166.41 | 2023 | Urolift |
| Sumitomo Pharma America, INC. | $164.00 | 2023-2025 | Gemtesa, Orgovyx |
| Ferring Pharmaceuticals INC. | $160.56 | 2019-2025 | Adstiladrin |
| Pfizer INC. | $149.14 | 2019-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $142.15 | 2019-2024 | |
| Antares Pharma, INC. | $141.64 | 2019-2025 | Xyosted |
| Endo USA, INC. | $139.89 | 2024-2025 | Xiaflex, Aveed |
| Calyxo, INC. | $139.32 | 2025 | Cvac Aspiration System |
| Dornier Medtech America, INC | $138.51 | 2025 | Dornier Medtech |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Laborie Medical Technologies Corp. | $137.13 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Astellas Pharma Global Development | $131.61 | 2024 | Xtandi |
| Abbvie INC. | $124.43 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $122.11 | 2025 | Lynparza |
| Janssen Scientific Affairs, LLC | $112.26 | 2025 | |
| Urogen Pharma, INC. | $111.48 | 2020-2024 | Jelmyto |
| Endo Pharmaceuticals INC. | $106.90 | 2019-2024 | Xiaflex, Aveed |
| Progenics Pharmaceuticals, INC. | $101.31 | 2022-2025 | |
| 180 Medical, INC. | $80.28 | 2022-2024 | Gentlecath Glide |
| Tolmar, INC. | $77.44 | 2023-2025 | Eligard, Jatenzo |
| Dendreon Pharmaceuticals LLC | $70.53 | 2019-2020 | |
| Amgen INC. | $67.58 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $67.53 | 2022 | |
| Coloplast Corp | $58.34 | 2020-2024 | |
| Intuitive Surgical, INC. | $53.62 | 2019 | |
| Myovant Sciences INC. | $53.60 | 2022 | |
| Blue Earth Diagnostics | $48.21 | 2024-2025 | Posluma |
| Rochester Medical Corporation | $46.24 | 2020-2022 | |
| Immunitybio, INC. | $44.66 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $44.07 | 2025 | Lynparza, Keytruda |
| Telix Pharmaceuticals | $36.40 | 2024 | Illuccix |
| Ambu INC. | $36.21 | 2024 | |
| Baxter Healthcare | $36.06 | 2024 | Tisseel |
| Procept Biorobotics Corporation | $34.98 | 2022 | |
| Novartis Pharmaceuticals Corporation | $31.17 | 2025 | |
| Axonics, INC. | $26.21 | 2023 | Bulkamid |
| Accord Healthcare, INC. | $24.88 | 2024 | |
| Travere Therapeutics, INC. | $20.75 | 2019-2020 | |
| Provepharm INC. | $20.52 | 2025 | Bludigo |
| Palette Life Sciences, INC. | $20.30 | 2022 | |
| Amniox Medical, INC. | $18.61 | 2019 | |
| Becton, Dickinson and Company | $14.18 | 2025 | Bard Urinary Drainage Bag |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robin Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.